March 16, 2022 Philips Vue PACS interoperability enhances access, quality of care, and patient experience in Scottish Breast Screening Program Image sharing across regional breast screening centers helps better manage the post COVID-19 backlog of screening appointments Amsterdam, the Netherlands
March 16, 2022 Integration of SecureLink critical access management technology with Philips Remote Services framework provides advanced security for remote technical and clinical support Amsterdam, the Netherlands and Orlando, Florida, USA – Royal Philips (NYSE: PHG, AEX: PHIA), a global
Spring update to support tax, revenue recognition and regional compliance mandates to help customers expand globally San Francisco, CA, March 16, 2022 (GLOBE NEWSWIRE) — Fresh off its recent round of funding, Chargebee, the leading subscription management platform, today announced
SHANGHAI, China, March 16, 2022 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences”, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced today that the first patient
Near the Ocean, Hear the Ocean in Southampton 146 Foster Crossing Southampton SOUTHAMPTON, N.Y., March 16, 2022 (GLOBE NEWSWIRE) — Looking for turnkey, inviting elegance with proximity to beaches? Look no further. Positioned just four houses from the Atlantic Ocean
Industry-Leading Automotive AI Software Now Available on World-Class Automotive Grade AI Perception, Fusion and Central Processing Platform Ambarella and Helm.ai High-End ADAS Software Integration SANTA CLARA, Calif. and MENLO PARK, Calif., March 16, 2022 (GLOBE NEWSWIRE) — Ambarella, Inc. (NASDAQ:
Congenica to Provide Tertiary Analysis for Whole Genome Sequencing for Hong Kong Genome Project Cambridge, United Kingdom – 16 March 2022 – Congenica, the digital health company enabling rapid and accurate analysis of complex genomic data to transform people’s lives,
Kither Biotech Raises €18.5 Million Series B and Appoints Dr. Vincent Metzler as Chief Executive Officer Proceeds to support the further development of lead asset KIT2014 in cystic fibrosis through to Phase 1/2A clinical trial International syndicate of new investors